approval
saveOMVOH (MIRIKIZUMAB-MRKZ) — FDA approval
community read0 votes
Sponsor: ELI LILLY AND CO. Form: INJECTABLE. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 4
same company · ±60 days · 6
- approvalselpercatinib: RETEVMO (SELPERCATINIB) — FDA approvalApr 10, 2024
- approvalselpercatinib: RETEVMO (SELPERCATINIB) — FDA approvalApr 10, 2024
- approvalselpercatinib: RETEVMO (SELPERCATINIB) — FDA approvalMay 29, 2024
- approvalZEPBOUND: ZEPBOUND (TIRZEPATIDE) — FDA approvalMar 28, 2024
- approvalselpercatinib: RETEVMO (SELPERCATINIB) — FDA approvalJun 12, 2024
- approvalselpercatinib: RETEVMO (SELPERCATINIB) — FDA approvalJun 12, 2024
comments(0)
5-min edit window · permanent after that